Platinum, Palladium...
Health Care: Drugs
Ariad Pharmaceuticals (ARIA: NASDAQ)
$17.87 0.08 | 0.47%
06/19/13 - 11:50 AM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | -34,951 | 174,486 | 220,875 | 81,939 | -105,968 | -123,967 | -140,567 |
| Shares Bought | 504,166 | 646,105 | 538,273 | 149,439 | 93,550 | 150,394 | 215,106 |
| Shares Sold | 539,117 | 471,619 | 317,398 | 67,500 | 199,518 | 274,361 | 355,673 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 157.40M | 157.16M | 135.66M | 135.34M | 136.35M | 134.00M | 133.60M |
| Shares Bought | 35.12M | 34.97M | 23.73M | 23.35M | 23.62M | 22.23M | 20.07M |
| Shares Sold | 14.38M | 14.61M | 22.65M | 22.00M | 21.98M | 15.61M | 15.80M |
Portfolios with ARIA
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProSteven Cohen - SAC Capital
- ProDaniel Loeb - Third Point
- ContributorBreakout Stocks Of The Week...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorStocks At New 52-Week Highs...
Latest ARIA Headlines from TheStreet
- Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard 05.30.13 | 05:05 pm
- Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Winner 05.22.13 | 05:05 pm
- Ariad Stock Falls On Unusually High Volume (ARIA) 05.16.13 | 12:05 pm
- 10 ASCO '13 Abstracts You Can Read Right Now 05.15.13 | 06:05 pm
- Biotech Stock Mailbag: MannKind, Ariad, Oncolytics Biotech 04.05.13 | 07:04 am
- Ariad CEO Strikes Back, Insists Leukemia Drug Is Fine 04.04.13 | 10:04 am
- Ariad Stock Falls On Unusually High Volume (ARIA) 04.03.13 | 02:04 pm
- The Survey Says: Ariad's Leukemia Drug Is Toxic 04.03.13 | 01:04 pm
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Ariad Pharmaceuticals (ARIA): Drugs' Highlighted Dud Of The Day 03.28.13 | 05:03 pm
Press Releases for ARIA
- ARIAD Honored With Gold Stevie® Awards As Pharmaceutical Company Of The Year At 2013 American Business Awardssm - Business Wire 06.18.13 | 02:06 pm
- ARIAD Announces Webcast Of Its Annual Shareholders Meeting - Business Wire 06.13.13 | 07:06 am
- ARIAD Announces That Iclusig™ (Ponatinib) Receives Positive CHMP Opinion For Approval In The European Union - Business Wire 03.22.13 | 08:03 am
- ARIAD Announces Presentations Of Preclinical Data At American Association For Cancer Research Annual Meeting - Business Wire 03.20.13 | 07:03 am
- ARIAD To Present At Barclays Global Healthcare Conference - Business Wire 03.06.13 | 07:03 am
- ARIAD To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.28.13 | 07:02 am
- ARIAD Reports 2012 Financial Results And Outlines Key Objectives For 2013 - Business Wire 02.25.13 | 07:02 am
- Jonathan E. Dickinson, General Manager, ARIAD Pharmaceuticals (Europe), Sàrl (Photo: Business Wire) - Business Wire 02.21.13 | 02:02 am
- ARIAD To Present At The RBC Capital Markets Healthcare Conference - Business Wire 02.19.13 | 07:02 am
- ARIAD To Present At The Leerink Swann Global Healthcare Conference - Business Wire 02.08.13 | 07:02 am
Partner Headlines for ARIA
- ARIAD Presents Long-Term Durability-of-Response Data from Phase 1 Trial of Iclusig - Benzinga 06.02.13 | 09:06 am
- ARIAD Announces Updated Clinical Results on AP26113 in Patients with Non-Small Cell Lung Cancer - Benzinga 06.02.13 | 09:06 am
- ARIAD Announces Analysis of Cardiovascular Risk Profile of Patients in Pivotal PACE Trial of Iclusig - Benzinga 06.01.13 | 12:06 pm
- Ariad Pharmaceuticals Earnings: Here’s Why Investors Like These Results - Wall St. Cheat Sheet 05.07.13 | 10:05 am
- 80 million victims of sickeningly high medical costs - MSN Money 05.02.13 | 09:05 am
- Pre-Market Earnings Report for February 25, 2013 : LOW, FE, HTZ, DCI, KOS, ARIA, DDD, BGC, CTB, CWH, HL, DNDN - NASDAQ 02.22.13 | 09:02 pm
- Mid-Week Biopharma Catalyst Trades To Consider - Seeking Alpha 12.13.12 | 09:12 am
- UPDATE: Dawson James Initiates Coverage on Ariad Pharmaceuticals with Market Outperform Rating, $32 PT - Benzinga 12.07.12 | 09:12 am
- Data Published on ARIAD Candidate - Analyst Blog - Zacks 11.30.12 | 02:11 pm
- 5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments - Seeking Alpha 10.09.12 | 09:10 am
